Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects

Lignende værker

• Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
  af: Cariou, Bertrand, et al.
  Udgivet: (2011)
• The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model
  af: Liu, Linfu, et al.
  Udgivet: (2020)
• Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults
  af: Cariou, Bertrand, et al.
  Udgivet: (2011)
• Fibrates, glitazones, and peroxisome proliferator-activated receptors
  af: Lalloyer, Fanny, et al.
  Udgivet: (2010)
• Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production
  af: Colin, Sophie, et al.
  Udgivet: (2013)